Characteristics and Abstinence Outcomes Among Tobacco Quitline Enrollees Using Medication
Friday, April 30, 2010
Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy.
Biazzo LL, Froshaug DB, Harwell TS, Beck HN, Haugland C, Campbell SL, Helgerson SD. Nicotine Tob Res. 2010 Apr 8. [Epub ahead of print]
This study examined the characteristics of callers to the Montana quitline selecting varenicline vs. NRT, and evaluated quitting outcomes at 3 and 6 months. Over 6,800 callers were included in the study. Those selecting varenicline had different characteristics than those selecting NRT. Use of varenicline was associated with higher quit rates than use of NRT at 3 and 6 months. Independently, people who used varenicline, were older, were insured, and received a larger number of counseling sessions were more likely to have quit at 3 months. However, only age and a greater number of counseling sessions were independently associated with quitting at 6 months. The authors conclude that the addition of varenicline enhances 3-month quit rates, and that commitment to quit may be the most important predictor of successful quitting.
|
|
Email to a Friend